Cell-free DNA in newly diagnosed patients with glioblastoma – a clinical prospective feasibility study

Background: Glioblastoma (GB) is an incurable brain cancer with limited treatment options. The aim was to test the feasibility of using cell-free DNA (cfDNA) to support evaluation of treatment response, pseudo-progression and whether progression could be found before clinical and/or radiologic progr...

Descripción completa

Detalles Bibliográficos
Autores principales: Nørøxe, Dorte Schou, Østrup, Olga, Yde, Christina Westmose, Ahlborn, Lise Barlebo, Nielsen, Finn Cilius, Michaelsen, Signe Regner, Larsen, Vibeke Andrée, Skjøth-Rasmussen, Jane, Brennum, Jannick, Hamerlik, Petra, Poulsen, Hans Skovgaard, Lassen, Ulrik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2019
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6633897/
https://www.ncbi.nlm.nih.gov/pubmed/31320993
http://dx.doi.org/10.18632/oncotarget.27030

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6633897/
https://www.ncbi.nlm.nih.gov/pubmed/31320993
http://dx.doi.org/10.18632/oncotarget.27030

Ejemplares similares